These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39314786)

  • 1. Bacterial infections and outcomes of inpatients with COVID-19 in the intensive care unit during the delta-dominant phase: the worst wave of pandemic in Iran.
    Akbari M; Dehghani Y; Shirzadi M; Pourajam S; Hosseinzadeh M; Sajadi M; Alenaseri M; Siavash M; Jafari L; Solgi H
    Front Public Health; 2024; 12():1411314. PubMed ID: 39314786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
    Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
    Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
    Litwin A; Fedorowicz O; Duszynska W
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
    [No Abstract]   [Full Text] [Related]  

  • 4. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections.
    Gaspari R; Spinazzola G; Teofili L; Avolio AW; Fiori B; Maresca GM; Spanu T; Nicolotti N; De Pascale G; Antonelli M
    Eur J Clin Invest; 2021 Dec; 51(12):e13687. PubMed ID: 34599600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.
    Hesni E; Sayad B; Khosravi Shadmani F; Najafi F; Khodarahmi R; Rahimi Z; Bozorgomid A; Sayad N
    BMC Infect Dis; 2022 Mar; 22(1):319. PubMed ID: 35361161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study.
    Siwakoti S; Subedi A; Sharma A; Baral R; Bhattarai NR; Khanal B
    Antimicrob Resist Infect Control; 2018; 7():114. PubMed ID: 30275945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome.
    Bardi T; Pintado V; Gomez-Rojo M; Escudero-Sanchez R; Azzam Lopez A; Diez-Remesal Y; Martinez Castro N; Ruiz-Garbajosa P; Pestaña D
    Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):495-502. PubMed ID: 33389263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial profiles and their antibiotic resistance background in superinfections caused by multidrug-resistant bacteria among COVID-19 ICU patients from southwest Iran.
    Akrami S; Montazeri EA; Saki M; Neisi N; Khedri R; Dini SA; Motlagh AA; Ahmadi F
    J Med Virol; 2023 Jan; 95(1):e28403. PubMed ID: 36515422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
    Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
    Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and effect on mortality of superinfections in a newly established COVID-19 respiratory sub-intensive care unit at University Hospital in Rome.
    Iacovelli A; Oliva A; Siccardi G; Tramontano A; Pellegrino D; Mastroianni CM; Venditti M; Palange P
    BMC Pulm Med; 2023 Jan; 23(1):30. PubMed ID: 36670381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil.
    Polly M; de Almeida BL; Lennon RP; Cortês MF; Costa SF; Guimarães T
    Am J Infect Control; 2022 Jan; 50(1):32-38. PubMed ID: 34562526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-infection in critically ill patients with COVID-19: an observational cohort study from England.
    Baskaran V; Lawrence H; Lansbury LE; Webb K; Safavi S; Zainuddin NI; Huq T; Eggleston C; Ellis J; Thakker C; Charles B; Boyd S; Williams T; Phillips C; Redmore E; Platt S; Hamilton E; Barr A; Venyo L; Wilson P; Bewick T; Daniel P; Dark P; Jeans AR; McCanny J; Edgeworth JD; Llewelyn MJ; Schmid ML; McKeever TM; Beed M; Lim WS
    J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33861190
    [No Abstract]   [Full Text] [Related]  

  • 13. Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.
    Karruli A; Boccia F; Gagliardi M; Patauner F; Ursi MP; Sommese P; De Rosa R; Murino P; Ruocco G; Corcione A; Andini R; Zampino R; Durante-Mangoni E
    Microb Drug Resist; 2021 Sep; 27(9):1167-1175. PubMed ID: 33600262
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit.
    Cornejo-Juárez P; Vilar-Compte D; Pérez-Jiménez C; Ñamendys-Silva SA; Sandoval-Hernández S; Volkow-Fernández P
    Int J Infect Dis; 2015 Feb; 31():31-4. PubMed ID: 25528484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistant bacterial infections in severely ill COVID-19 patients admitted in a national referral and teaching hospital, Kenya.
    Mutua JM; Njeru JM; Musyoki AM
    BMC Infect Dis; 2022 Nov; 22(1):877. PubMed ID: 36418990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalent bacterial infections in intensive care units of Shiraz University of medical sciences teaching hospitals, Shiraz, Iran.
    Hassanzadeh P; Motamedifar M; Hadi N
    Jpn J Infect Dis; 2009 Jul; 62(4):249-53. PubMed ID: 19628899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.
    Vincent JL; Bihari DJ; Suter PM; Bruining HA; White J; Nicolas-Chanoin MH; Wolff M; Spencer RC; Hemmer M
    JAMA; 1995 Aug 23-30; 274(8):639-44. PubMed ID: 7637145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study.
    Agaba P; Tumukunde J; Tindimwebwa JVB; Kwizera A
    BMC Res Notes; 2017 Jul; 10(1):349. PubMed ID: 28754148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions.
    Bahçe YG; Acer Ö; Özüdoğru O
    Microb Pathog; 2022 Mar; 164():105409. PubMed ID: 35041973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparative Study on Bacterial Co-Infections and Prevalence of Multidrug Resistant Organisms among Patients in COVID and Non-COVID Intensive Care Units.
    Sathyakamala R; Peace AR; Shanmugam P
    J Prev Med Hyg; 2022 Mar; 63(1):E19-E26. PubMed ID: 35647371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.